Risk Ratios of psychotic symptoms, according to the 8 exposure

Biomedicines, Free Full-Text

Hans-Ulrich WITTCHEN, Technische Universität Dresden, Dresden, TUD, Institute and Outpatient Clinics of Psychiatrics and Psychotherapy

Association between psychotic features and days of use of substances in

Investigating the symptomatic and morphological changes in the brain based on pre and post-treatment: A critical review from clinical to neuroimaging studies on schizophrenia - IBRO Neuroscience Reports

Brain Sciences, Free Full-Text

Precision medicine for psychotic disorders: objective assessment, risk prediction, and pharmacogenomics

Polygenic risk scores across the extended psychosis spectrum

Johan LATASTER, Professor (Associate), PhD, Associate prof., Open Universiteit Nederland, Heerlen, OU, Department of Psychology

Neurophysiology in psychosis: The quest for disease biomarkers

Do environmental risk factors for the development of psychosis distribute differently across dimensionally assessed psychotic experiences?

Precursors to Schizophrenia: Do Biological Markers Have Specificity?

The temporal dynamics of transition to psychosis in individuals at clinical high-risk (CHR-P) shows negative prognostic effects of baseline antipsychotic exposure: a meta-analysis

Mortality in Offspring of Parents With Psychotic Disorders: A Critical Review and Meta-Analysis

White matter microstructure and the clinical risk for psychosis: A diffusion tensor imaging study of individuals with basic symptoms and at ultra-high risk - ScienceDirect